Table 3.

Comparison of Postoperative Adverse Events Between Therapeutic Groups

Variable	Overall, n = 80	CA Group, n = 40	ESP Group, n = 40	P value
None	47 (58.75)	22 (55)	25 (62.5)	0.5
Cardiovascular	3 (3.75)	1 (2.5)	2 (5)
Pulmonary and Pneumonia	8 (10)	4 (10)	4 (10)
Fever	4 (5)	3 (7.5)	1 (2.5)
Gastrointestinal	4 (2.5)	1 (2.5)	3 (7.5)
Bleeding and reintervention	2 (2.5)	1 (2.5)	1 (2.5)
Electrolytic disturbances	1(1.25)	1 (2.5)	0
Tracheostomy and pulmonary	1 (1.25)	1 (2.5)	0
Cardiovascular and pulmonary	1 (1.25)	0	1 (2.5)
Cardiovascular and gastrointestinal (NV)	1 (1.25)	0	1 (2.5)
Cardiovascular and neurologic (convulsions)	1 (1.25)	0	1 (2.5)
Cardiovascular and urinary	1 (1.25)	1 (2.5)	0
Cardiovascular, pulmonary and infectious	1 (1.25)	0	1 (2.5)
Pulmonary and renal or pulmonary with tracheostomy	2 (2.5)	2 (5.0)	0
Gastrointestinal and pulmonary	1 (1.25)	1 (2.5)	0
Gastrointestinal and bleeding with blood transfusion	1 (1.25)	1 (2.5)	0
Reoperation for bleeding control	1 (1.25)	1 (2.5)	0